Cargando…
Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
BACKGROUND: The aim of this study is to evaluate the anticancer activity of vorinostat-incorporated nanoparticles (vorinostat-NPs) against HuCC-T1 human cholangiocarcinoma cells. Vorinostat-NPs were fabricated by a nanoprecipitation method using poly(dl-lactide-co-glycolide)/poly(ethylene glycol) co...
Autores principales: | Kwak, Tae Won, Kim, Do Hyung, Jeong, Young-Il, Kang, Dae Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583727/ https://www.ncbi.nlm.nih.gov/pubmed/26410576 http://dx.doi.org/10.1186/s12951-015-0122-4 |
Ejemplares similares
-
Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells
por: Kwak, Tae Won, et al.
Publicado: (2013) -
Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2017) -
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2016) -
Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
por: Kim, Do Hyung, et al.
Publicado: (2013) -
Defensive mechanism in cholangiocarcinoma cells against oxidative stress induced by chlorin e6-based photodynamic therapy
por: Lee, Hye Myeong, et al.
Publicado: (2014)